Dexamethasone Induces Rapid Serine-Phosphorylation and Membrane Translocation of Annexin 1 in a Human Folliculostellate Cell Line via a Novel Nongenomic Mechanism Involving the Glucocorticoid Receptor, Protein Kinase C, Phosphatidylinositol 3-Kinase, and Mitogen-Activated Protein Kinase
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Our recent studies on rat pituitary tissue suggest that the annexin 1 (ANXA1)-dependent inhibitory actions of glucocorticoids on ACTH secretion are effected via a paracrine mechanism that involves protein kinase C (PKC)-dependent translocation of a serine-phosphorylated species of ANXA1 (Ser-P-ANXA1) to the plasma membrane of the nonsecretory folliculostellate cells. In the present study, we have used a human folliculostellate cell line (PDFS) to explore the signaling mechanisms that cause the translocation of Ser-P-ANXA1 to the membrane together with Western blot analysis and flow cytometry to detect the phosphorylated protein. Exposure of PDFS cells to dexamethasone caused time-dependent increases in the expression of ANXA1 mRNA and protein, which were first detected within 2 h of steroid contact. This genomic response was preceded by the appearance within 30 min of substantially increased amounts of Ser-P-ANXA1 and by translocation of the phosphorylated protein to the cell surface. The prompt membrane translocation of Ser-P-ANXA1 provoked by dexamethasone was inhibited by the glucocorticoid receptor, antagonist, mifepristone, but not by actinomycin D or cycloheximide, which effectively inhibit mRNA and protein synthesis respectively in our preparation. It was also inhibited by a nonselective PKC inhibitor (PKC9–31), by a selective inhibitor of Ca2+-dependent PKCs (Go 6976) and by annexin 5 (which sequesters PKC in other systems). In addition, blockade of phosphatidylinositiol 3-kinase (wortmannin) or MAPK pathways with PD 98059 or UO 126 (selective for MAPK kinse 1 and 2) prevented the steroid-induced translocation of Ser-P-ANXA1 to the cell surface. These results suggest that glucocorticoids induce rapid serine phosphorylation and membrane translocation of ANXA1 via a novel nongenomic, glucocorticoid receptor-dependent mechanism that requires MAPK, phosphatidylinositiol 3-kinase, and Ca2+-dependent PKC pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of glucocorticoids to GR not only activates the receptor, but also liberates accessory proteins that participate in secondary signaling cascades.”
From Corticosteroids (2016) · cites this paper as [39]
In the citing paper
“For example, when released from the inactive GR protein complex, c-Src activates signaling cascades that inhibit phospholipase A2 activity, phosphorylate annexin 1, and impair the release of arachidonic acid38, 39.”
From Corticosteroids (2016) · cites this paper as [39]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Raynal, P., & Pollard, H. B. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(94)90019-1 · Cited by 1,099
Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate.
Nakanishi, H., Brewer, K. A., & Exton, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54107-7 · Cited by 965
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
FLOWER, R. J., & BLACKWELL, G. J. (1979) · Nature · doi:10.1038/278456a0 · Cited by 917
Self-citationWallner, B. P., Mattaliano, R. J., Hession, C., Cate, R. L., Tizard, R., Sinclair, L. K., Foeller, C., Chow, E. P., Browning, J. L., Ramachandran, K. L., et al. (1986) · Nature · doi:10.1038/320077a0 · Cited by 664
Toker, A., Meyer, M., Reddy, K. K., Falck, J. R., Aneja, R., Aneja, S., Parra, A., Burns, D. J., Ballas, L. M., & Cantley, L. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31643-0 · Cited by 553
Neurosteroids: Beginning of the story
Baulieu, E. E., Robel, P., & Schumacher, M. (2001) · International Review of Neurobiology · doi:10.1016/s0074-7742(01)46057-0 · Cited by 352
Croxtall, J. D., Choudhury, Q., & Flower, R. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703272 · Cited by 332
Self-citationGlucocorticoid Receptor-Like Antigen in Lymphoma Cell Membranes: Correlation to Cell Lysis
Gametchu, B. (1987) · Science · doi:10.1126/science.3563523 · Cited by 183
Research works printed but not linked: 1
- Mulla, 2000, Expression of Annexin 1 (lipocortin 1) and Annexin 5 in human pituitary tumors, J Endocr, 167
Cited by
Items 101–184 of 184
Omer, S., Meredith, D., Morris, J. F., & Christian, H. (2006) · Endocrinology · doi:10.1210/en.2006-0099 · Cited by 34
Self-citationXu, R., Weber, M.-C., Hu, X., Neumann, P., & Kamaly, N. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101664 · Cited by 30
Huang, M.-H., So, E. C., Liu, Y., & Wu, S. (2005) · Steroids · doi:10.1016/j.steroids.2005.09.009 · Cited by 26
Glucocorticoid Efficacy in Asthma is Improved Tissue Remodeling Upstream of Anti-Inflammation
Freishtat, R. J., Nagaraju, K., Jusko, W. J., & Hoffman, E. P. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181b91654 · Cited by 26
“18,19 Other than the well-characterized translocation of the GR from the cytosol to the nucleus, a few proteins, such as annexin A1, 5lipoxygenase, and S100A11, have been shown to translocate in response to GCs.(18,20) Synthetic GCs have also been shown in multiple tissues to decrease membrane fluidity by altering the…”
BackgroundAnnexin A1 as a potential prognostic biomarker for COVID‐19 disease: Case–control study
Çanacık, Ö., Sabırlı, R., Altıntaş, E., Karslı, E., Karış, D., Kaymaz, B., Sabirli, G. T., Kurt, Ö., & Köseler, A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14606 · Cited by 28
The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology
Jing, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052865 · Cited by 31
Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system
Yazid, S., Norling, L. V., & Flower, R. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.11.005 · Cited by 27
Self-citationAnnexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system
Buckingham, J. C., Solito, E., John, C., Tierney, T., Taylor, A. D., Flower, R., Christian, H., & Morris, J. F. (2003) · Cell Biochemistry and Function · doi:10.1002/cbf.1076 · Cited by 24
Self-citationMechanistic insights regarding neuropsychiatric and neuropathologic impacts of air pollution
Rentschler, K. M., & Kodavanti, U. P. (2024) · Critical Reviews in Toxicology · doi:10.1080/10408444.2024.2420972 · Cited by 31
“Inhibition of ACTH release by GR activation also occurs in the pituitary gland, with a response as early as 1–2 min, with a mechanism involving translocation of annexin-1 (Solito et al. 2003).”
Hastie, C., Masters, J. R., Moss, S. E., & Naaby‐Hansen, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800189200 · Cited by 21
Li, J.-L., Zhao, L., Cui, B., Deng, L., Ning, G., & Liu, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.38 · Cited by 23
Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions
Sinniah, A., Yazid, S., Bena, S., Oliani, S. M., Perretti, M., & Flower, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01313 · Cited by 21
Self-citationLack of Annexin 1 Results in an Increase in Corticotroph Number in Male but not Female Mice
Morris, J., Omer, S., Davies, E., Wang, E., John, C., Afzal, T., Wain, S., Buckingham, J., Flower, R., & Christian, H. (2006) · Journal of neuroendocrinology · doi:10.1111/j.1365-2826.2006.01481.x · Cited by 25
Self-citationBergström, I., Lundberg, A. K., Jönsson, S., Särndahl, E., Ernerudh, J., & Jonasson, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174177 · Cited by 19
Krogh, J., Videbech, P., Renvillard, S. G., Garde, A. H., Jørgensen, M. B., & Nordentoft, M. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2012.665081 · Cited by 21
“High cortisol levels provide a negative feedback at the hippocampal, hypothalamic and pituitary level through occupation of mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) (5, 6).”
BackgroundTherapeutic Potential of Annexin A1 Modulation in Kidney and Cardiovascular Disorders
Mozaffari, M. S. (2021) · Cells · doi:10.3390/cells10123420 · Cited by 17
Les glucocorticoïdes et leur récepteur : mécanismes d'action et conséquences cliniques
Roumestan, C., Gougat, C., Jaffuel, D., & Mathieu, M. (2004) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2004.01.012 · Cited by 34
Gu, Y.-T., Zhang, H., & Xue, Y. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.053 · Cited by 18
Supportive management in neuro-oncology: opportunities for patient care, teaching, and research
Junck, L. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200412000-00003 · Cited by 18
Annexin A1 accounts for an anti-inflammatory binding target of sesamin metabolites
Kabe, Y., Takemoto, D., Kanai, A., Hirai, M., Ono, Y., Akazawa, S., Horikawa, M., Kitagawa, Y., Handa, H., Rogi, T., et al. (2020) · npj Science of Food · doi:10.1038/s41538-020-0064-6 · Cited by 15
Chang, C., Wang, S., Huang, Z.-L., Wang, O. Y., Huang, M. I., Lu, L., Tarng, D., Chien, C., & Chien, E. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22070 · Cited by 15
“Such beneficial rapid non-genomic GC effects are therapeutically relevant to treatment, for example, when patients suffer from seasonal allergic rhinitis (Tillmann et al., 2004; Naumann et al., 2006).”
BackgroundDavies, E., Omer, S., Buckingham, J. C., Morris, J. F., & Christian, H. (2006) · Endocrinology · doi:10.1210/en.2006-0732 · Cited by 15
Self-citationPrognostic Significance of Annexin A1 Expression in Pancreatic Ductal Adenocarcinoma
Chen, C., Shen, J., Wang, F., Wan, R., & Wang, X. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.9.4707 · Cited by 15
Coagulation Activation by Lipopolysaccharides
Stief, T. W. (2007) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029607309256 · Cited by 16
“They act via rapid serine-phosphorylation of annexin 1 and translocation of annexin 1 to the membrane.(52) This results into an inhibition of phosphorylation of PLA2.”
BackgroundExpression of Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiomyocytes
Aguilar, D. C., Strom, J. G., Xu, B., Kappeler, K. V., & Chen, Q. M. (2012) · Cardiovascular Toxicology · doi:10.1007/s12012-012-9188-5 · Cited by 17
“For instance, GCs can activate kinasemediated signaling pathways within minutes through nongenomic GR-mediated signaling to regulate gene expression [20, 33, 34].”
BackgroundMeliton, A. Y., Muñoz, N. M., Zhu, X., & Leff, A. R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0707495 · Cited by 13
“The diverse biological properties of annexins depend on the N-terminal domain, which is unique in length and sequence and the potential sites for phosphorylation [5], glycosylation [6], and peptidase action [7].”
BackgroundNaumann, L., Feist, E., Straub, R. H., Burmester, G., & Buttgereit, F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.045 · Cited by 13
ANXA1Ac2-26 peptide reduces ID1 expression in cervical carcinoma cultures
Prates, J., Franco-Salla, G. B., dos Santos, A. R. D., Silva, W. A., da Cunha, B. R., Tajara, E. H., Oliani, S. M., & Rodrigues-Lisoni, F. C. (2015) · Gene · doi:10.1016/j.gene.2015.06.021 · Cited by 12
Annexin A1 Complex Mediates Oxytocin Vesicle Transport
Makani, V. S., Sultana, R., Sie, K. S., Orjiako, D., Tatangelo, M. D., Dowling, A., Cai, J., Pierce, W. M. J., Butterfield, D. A., Hill, J. W., et al. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12112 · Cited by 13
Diskin, C., Day, E. A., Henry, Ó. C., Toller-Kawahisa, J. E., & O'Neill, L. A. J. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200848 · Cited by 12
Glucocorticoid-induced ocular hypertension: origins and new approaches to minimize
Yorio, T., Patel, G. C., & Clark, A. F. (2020) · Expert Review of Ophthalmology · doi:10.1080/17469899.2020.1762488 · Cited by 9
“c-Src activates signaling cascades that inhibit phospholipase A2 activity and impair the release of arachidonic acid [45,46].”
BackgroundGlucocorticoid action in the anterior pituitary gland: Insights from corticotroph physiology
Shipston, M. J. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100358 · Cited by 12
Hayward, T., Young, A. P., Jiang, A., Crespi, E. J., & Coffin, A. B. (2019) · Hearing Research · doi:10.1016/j.heares.2019.03.002 · Cited by 11
Belvedere, R., Morretta, E., Novizio, N., Morello, S., Bruno, O., Brullo, C., & Petrella, A. (2021) · Biomolecules · doi:10.3390/biom11121758 · Cited by 10
“We have analyzed primary antibodies against pPKCα (phospho-Protein Kinase C alpha; rabbit polyclonal; 1:500; Thermo Fisher Scientific, Waltham, MA, USA), ERK (rabbit monoclonal; 1:1000; Cell Signaling Technology, Danvers, MA, USA), pERK (rabbit monoclonal; 1:1000; (phospho-Thr202/Tyr204; Cell Signaling Technology, Dan…”
Damazo, A. S., Flower, R. J., Solito, E., & Oliani, S. M. (2008) · Inflammation Research · doi:10.1007/s00011-007-7114-2 · Cited by 9
“Similar results were obtained after glucocorticoid treatment in isolated pituitary tissue [32, 40].”
MethodResultInfluentialSelf-citationReeves, E. K. M., Gordish‐Dressman, H., Hoffman, E. P., & Hathout, Y. (2009) · Proteome Science · doi:10.1186/1477-5956-7-26 · Cited by 9
“Additionally, glucocorticoids have been reported to translocate annexin A1 and 5-lipoxygenase and S100A11 to the cytoskeleton in response to glucocorticoid exposure [8,11,12].”
BackgroundNogami, H., Yamamoto, N., Hiraoka, Y., Aiso, S., Sugimoto, K., Yoshida, S., Shutoh, F., & Hisano, S. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12132 · Cited by 8
Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer
Queiroz, C. J. D. S., Nakata, C. M. D. A. G., Solito, E., & Damazo, A. S. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-13 · Cited by 7
“The samples from each patient were then incubated with the following primary antibodies in 1% BSA for 18 hours at 4°C in a humidified chamber: mouse anti-p16 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of 1:200; rabbit anti-ANXA1 (Invitrogen, Frederick, MD, USA) and mouse anti-p53 (Invitrogen, Freder…”
MethodSelf-citationNongenomic glucocorticoid signaling: New targets for immunosuppressive therapy?
Schoneveld, J. L. M., Fritsch-Stork, R. D. E., & Bijlsma, J. W. J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30635 · Cited by 7
van Stigt, A. C., Gualtiero, G., Cinetto, F., Dalm, V. A. S. H., IJspeert, H., & Muscianisi, F. (2024) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001032 · Cited by 6
The expression of Annexin A1 and A5 mRNA by gonadotropin-releasing hormone in LβT2 gonadotrope cells
Murata, T., Chiba, S., & Kawaminami, M. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0397 · Cited by 6
“Dexa‐ methasone induces serine phosphorylation and mem‐ brane translocation of ANXA1 through the PKC-MAPK pathway in human folliculostellate cells [24] and in‐ creases serine phosphorylated ANXA1 levels on the cell surface, through the PKC pathway in rat pituitary in vitro [25].”
BackgroundZhang, P., Li, L., Zeng, J., Yang, L.-R., Ren, L.-C., Liang, P., & Huang, X. (2009) · Inflammation Research · doi:10.1007/s00011-009-0106-7 · Cited by 6
“Some previous studies have demonstrated that the trafficking of annexin I from the cytoplasm to the cell surface is dependent on posttranslational modification (phosphorylation) [31, 32].”
Negić, N., Nestorović, N. M., Manojlović‐Stojanoski, M., Filipović, B. R., Šošić‐Jurjević, B., Milošević, V., & Sekulić, M. (2006) · PubMed · doi:10.5603/4572 · Cited by 6
Sung, H. J., Ryang, Y.-S., Kim, Y. S., Jang, S.-W., Na, D. S., & Ko, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.134 · Cited by 6
Uneven modulation of the annexin 1 system in osteoblast-like cells by dexamethasone
Giner, R. M., Mancini, L., Kamal, A. M., & Perretti, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.224 · Cited by 5
The anterior pituitary gap junctions: potential targets for toxicants
Vitale, M. L., & Pelletier, R. ‐. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.06.003 · Cited by 5
Filho, E. L. C., Silva, P. G. D. B., Maia, I. D. F. V. C., Wong, D. V. T., Lima‐Júnior, R. C. P., Farias, R. J., dos Anjos, M. A., Fonseca, S. G. D. C., Ribeiro, T. R., & Costa, F. W. G. (2024) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2024.08.008 · Cited by 4
Genomic and non-genomic effects of glucocorticoids on allergic rhinitis model in mice
Kusaka, E., Sugiyama, M., Senoo, N., Yamamoto, A., & Sugimoto, Y. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.03.030 · Cited by 4
Buckingham, J. C., & Flower, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00025-5 · Cited by 3
Self-citationLimitations in the Design of Critical Care Studies and Suggestions for Future Research Directions
Meduri, G. U., Lanini, S., & Smit, J. M. (2026) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2762-8278 · Cited by 4
Zhu, X., Liu, Y., Diao, F., Fan, J., Lu, J., & Xu, R. (2007) · Endocrine · doi:10.1007/s12020-007-0019-6 · Cited by 3
Molecular Mechanisms Conferring Resistance/Sensitivity to Glucocorticoid-Induced Apoptosis
Berrou, I., Krstic–Demonacos, M., & Demonacos, C. (2012) · InTech eBooks · doi:10.5772/51467 · Cited by 3
Cell Signalling Within Pituitary, the Master Gland of the Endocrine System
Pereira, S. S., Lobato, C. B., & Monteiro, M. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-44436-5_2 · Cited by 4
Sakuma, E., Wada, I., Otsuka, T., Wakabayashi, K., Ito, K., Soji, T., & Herbert, D. C. (2012) · Microscopy Research and Technique · doi:10.1002/jemt.22108 · Cited by 3
Individualized Treatment for Allergic Rhinitis
Cho, S. W., & Kim, D.-Y. (2017) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2017.9.5.383 · Cited by 2
“For example, when liberated from the GR complex, c-Src activates multiple kinase cascades that lead to the phosphorylation of annexin 1, inhibition of cytosolic phospholipase A2 activity, and impaired release of arachidonic acid.(13) There are many isoforms of the GR.”
BackgroundRapid and Nongenomic Glucocorticoid Signaling in Rainbow Trout
Dindia, L. A. (2013) · UWSpace (University of Waterloo) · Cited by 3
Epis, R., Rovetta, G., Ferrari, G., Bonfanti, C., Careccia, G., & Messina, G. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70333 · Cited by 1
“This leads to reduced expression of IL-6, TNFα and COX-2 and increased levels of Annexin A1 and IL-10 [107].”
Anti-inflammatory glucocorticoids and annexin 1
Perretti, M., & Flower, R. J. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7506-5_8 · Cited by 1
“One example is linked to the externalisation of annexin 1, which occurs within the first 5–10 min post-GC exposure, and may differ among different GC [26, 27 ].”
BackgroundSelf-citationBergström, I. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-114123 · Cited by 1
Dietrich, J. (2006) · Wiley eBooks · doi:10.1002/9783527611225.ch13 · Cited by 1
Wehmeyer, L. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 1
Novel Aspects of Glucocorticoids Actions on Energy Homeostasis and Hydromineral Balance
Ruginsk, S. G., Cesar, R., Borges, B. C., Torres, E., Elias, L. L. K., & Antunes‐Rodrigues, J. (2012) · InTech eBooks · doi:10.5772/53266
“In pituitaryderived cells, the use of a GR antagonist prevented the dexamethasone-induced translocation of annexin-1, which was implicated in the rapid inhibition of adrenocorticotrophic hormone (ACTH) release (Buckingham et al., 2003; Solito et al., 2003; Tierney et al., 2003).”
Naumann, L. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15181 · Cited by 3
“…dass Dexamethason die Serin-Phosphorylierung von Annexin 1 und die Translokation an die Zellmembran innerhalb von 30 Minuten induziert und dass dieser PKC- und IP3-abhängige Signaltransduktionsweg durch RU486, nicht aber durch Aktinomycin oder Cycloheximid blockierbar ist (Solito et al. 2003).”
BackgroundCharacterization of Immune Response in Corticosteroid-refractory Severe Asthma in Humans and Mice
Raundhal, M. R. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
Mitochondria and energetics stress : signaling pathways and cellular adaptations.
Desquiret‐Dumas, V., & Malthièry, Y. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Wehmeyer, L. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Addou-Regnard, M. (2015) · HAL
Takahama, C. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2016.tde-26092016-125014 · Cited by 1
Corticosteroids: Targeting Multiple Cytokines and Chemokines
Stewart, M. W. (2017) · Springer eBooks · doi:10.1007/978-981-10-3509-8_5 · Cited by 1
A Hierarchical Model of the Hypothalamo-Adreno-Pituitary systemPreprint
Rota, C. L., Vuza, D. T., & Climescu-Haulica, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/837724
“There are at least two different kind of transduction for GC : i) binding and activation of intracellular receptors followed by nuclear translocation → DNA binding → transcription regulation, mediated by intracellular GR and MR, or ii) binding and activation of GR membrane receptors followed by a nongenomic signaling…”
BackgroundInfluentialTOPICAL GLUCOCORTICOSTEROIDS IN ATOPIC DERMATITIS: FROM MECHANISMS TO CLINICAL PRACTICE
Pampura, A. N. (2014) · Russian Journal of Allergy · doi:10.36691/rja548
Filho, E. L. C., Silva, P. G. D. B., Maia, I. D. F. V. C., Wong, D. V. T., Lima‐Júnior, R. C. P., Ribeiro, T. R., Farias, R. J., dos Anjos, M. A., Fonseca, S. G. D. C., & Costa, F. W. G. (2024) · Research Square · doi:10.21203/rs.3.rs-4197275/v1
Genome-wide CRISPR screening identifies Annexin A1 as a facilitator of porcine astrovirus entry
Luo, Y., Dong, Q., Yi, S., Zhang, W., Du, Y., Fang, Q., Zhang, W., Ouyang, K., Chen, Y., YeShi, Y., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013943
“All annexins possess a conserved C-terminal core composed of four annexin repeats (Repeat I to IV, except eight in ANXA6), each harboring characteristic type II calcium-binding sites formed by hydrophobic interactions that maintain structural stability [32,33].”
IMPACT DE L’HYPERCORTICISME SUR L’AXE GONADOTROPE FEMELLE
Ayrout, M. (2018) · theses.fr (ABES) · doi:10.70675/194a6ff5z99f6z4ef0z800ez5473528e7a30 · Cited by 1
Implication du récepteur des glucocorticoïdes en physiopathologie humaine
Vitellius, G. (2019) · theses.fr (ABES) · doi:10.70675/84630f11zbc82z43a6z8604z69024f4ae7dd
Annexine A1 : dissémination et microenvironnement tumoral
Delorme, S. (2020) · theses.fr (ABES) · doi:10.70675/4e6e1c64z0a30z47bczb53cz2e00956cfcd8
Stéroïdomique corticosurrénalienne par LC-MS/MS : applications en endocrinologie pédiatrique
Travers, S. A. A. (2020) · theses.fr (ABES) · doi:10.70675/84cf9c3bze93ez41dcza251z559f27f3c6a6
Glucocorticoid receptor activity in triple negative breast cancer
Noureddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/13ab50cfz7edbz4a44z918aza657b9614a4d · Cited by 1
Architect or Destroyer: The Diversity of Glucocorticoid Receptor Signaling Pathways in the Brain
Shkarina, L. N., Khaybullina, R., Primak, A. L., Дмитриевич, Б. К., Станиславович, Д. С., & Karagyaur, M. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209027
Steroid Hormone Receptors and Signal Transduction Processes
Klinge, C. M. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_9-2
Mechanisms of Altered Glucocorticoid Sensitivity
Yang, N. (2013) · Research Explorer (The University of Manchester) · Cited by 1
Metadata
- Authors
- Solito, E., Mulla, A., Morris, J. F., Christian, H. C., Flower, R. J., & Buckingham, J. C.
- Affiliations
- Hammersmith Hospital (GB)
- University of Oxford (GB)
- William Harvey Research Institute (GB)
- Corresponding author
- Solito, Egle
- Buckingham, Julia C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-04-01
- Volume
- 144
- Issue
- 4
- Pages
- 1164-1174
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2069585979
- Cited by
- 184
- References
- 67
- Citations by year
- 2026: 5 · 2024: 5 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- annexin A1, dexamethasone, glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, mitogen-activated protein kinase, serine phosphorylation, membrane translocation, folliculostellate cells, ACTH secretion, mifepristone, annexin V
- MeSH terms
- Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Membrane, Dexamethasone, Enzyme Inhibitors, Glucocorticoids, Humans, Phosphorylation, Pituitary Neoplasms, Protein Kinase C, Rabbits, Receptors, Glucocorticoid, Serine, Tumor Cells, Cultured, Gene Expression, Annexin A1, Adenocarcinoma, Follicular, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.